Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
99.00
-2.60 (-2.56%)
Last updated: Jan 19, 2026, 9:36 AM HKT

HKG:2659 Statistics

Total Valuation

HKG:2659 has a market cap or net worth of HKD 31.95 billion. The enterprise value is 31.72 billion.

Market Cap31.95B
Enterprise Value 31.72B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

HKG:2659 has 325.98 million shares outstanding.

Current Share Class 154.33M
Shares Outstanding 325.98M
Shares Change (YoY) n/a
Shares Change (QoQ) +4.70%
Owned by Insiders (%) 36.60%
Owned by Institutions (%) 13.87%
Float 72.92M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 624.83
PB Ratio 32.77
P/TBV Ratio 33.22
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -76.12
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -116.34

Financial Position

The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.28.

Current Ratio 2.09
Quick Ratio 1.58
Debt / Equity 0.28
Debt / EBITDA n/a
Debt / FCF -0.99
Interest Coverage -59.10

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) -21.80%
Return on Capital Employed (ROCE) -28.00%
Revenue Per Employee 146,920
Profits Per Employee -1.20M
Employee Count 348
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 67.38
Average Volume (20 Days) 281,287

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2659 had revenue of HKD 51.13 million and -416.66 million in losses. Loss per share was -7.40.

Revenue51.13M
Gross Profit 50.08M
Operating Income -337.79M
Pretax Income -416.66M
Net Income -416.66M
EBITDA -304.19M
EBIT -337.79M
Loss Per Share -7.40
Full Income Statement

Balance Sheet

The company has 497.93 million in cash and 269.81 million in debt, with a net cash position of 228.12 million or 0.70 per share.

Cash & Cash Equivalents 497.93M
Total Debt 269.81M
Net Cash 228.12M
Net Cash Per Share 0.70
Equity (Book Value) 974.79M
Book Value Per Share 16.92
Working Capital 342.29M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -166.67 million and capital expenditures -105.98 million, giving a free cash flow of -272.64 million.

Operating Cash Flow -166.67M
Capital Expenditures -105.98M
Free Cash Flow -272.64M
FCF Per Share -0.84
Full Cash Flow Statement

Margins

Gross Margin 97.96%
Operating Margin -660.67%
Pretax Margin -814.93%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:2659 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -1.30%
FCF Yield -0.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:2659 has an Altman Z-Score of -1.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.29
Piotroski F-Score 2